Neuropathic Pain

Treating postherpetic neuralgia patients with the oral opioid agonist tramadol may significantly reduce moderate to severe nerve pain.

Achieving safe, effective pain control for inpatients can challenge even experienced clinicians. Components of successful pain control include avoiding pain crises while still steering clear of respiratory depression, being confident with equianalgesic calculations, and transitioning to the outpatient setting.

Results from a small study indicate patients with difficult-to-treat diabetic peripheral neuropathy (DPN) may benefit from therapy with tanezumab, a humanized monoclonal antibody against nerve growth factor.

Researchers successfully treated a patient with refractory complex regional pain syndrome by inducing a coma with ketamine and dexmedetomidine.

Clinicians who treat patients with postherpetic neuralgia (PHN) can select from a wide range of agents that have been shown to have some clinical efficacy, including topical analgesics such as the lidocaine patch.

Study results show that patients suffering from diabetic peripheral neuropathy treated with tapentadol reported significant improvement in their pain.

For the first time, a study featured in The Journal of Pain examines the associations between pain quality and changes in patient functioning and quality of life, using carpal tunnel syndrome sufferers as study participants.